Fusion protein of human fibroblast growth factor-21 and exendin-4

Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Chongqing Fagen Biomedical Inc
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Chongqing Fagen Biomedical Inc
description	Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08809499</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08809499</sourcerecordid><originalsourceid>FETCH-uspatents_grants_088094993</originalsourceid><addsrcrecordid>eNrjZHB0Ky3OzM9TKCjKL0nNzFPIT1PIKM1NzFNIy0wqyk_KSSwuUUgvyi8vyVBIS0wuyS_SNTJUSMxLUUitSM1LyczTNeFhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwMLCwNLE0tKYCCUAih0x6A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fusion protein of human fibroblast growth factor-21 and exendin-4</title><source>USPTO Issued Patents</source><creator>Chongqing Fagen Biomedical Inc</creator><creatorcontrib>Chongqing Fagen Biomedical Inc</creatorcontrib><description>Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.</description><language>eng</language><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8809499$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8809499$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Chongqing Fagen Biomedical Inc</creatorcontrib><title>Fusion protein of human fibroblast growth factor-21 and exendin-4</title><description>Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZHB0Ky3OzM9TKCjKL0nNzFPIT1PIKM1NzFNIy0wqyk_KSSwuUUgvyi8vyVBIS0wuyS_SNTJUSMxLUUitSM1LyczTNeFhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwMLCwNLE0tKYCCUAih0x6A</recordid><startdate>20140819</startdate><enddate>20140819</enddate><creator>Chongqing Fagen Biomedical Inc</creator><scope>EFH</scope></search><sort><creationdate>20140819</creationdate><title>Fusion protein of human fibroblast growth factor-21 and exendin-4</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_088094993</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Chongqing Fagen Biomedical Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>Chongqing Fagen Biomedical Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fusion protein of human fibroblast growth factor-21 and exendin-4</title><date>2014-08-19</date><risdate>2014</risdate><abstract>Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_grants_08809499
source	USPTO Issued Patents
title	Fusion protein of human fibroblast growth factor-21 and exendin-4
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A35%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=Chongqing%20Fagen%20Biomedical%20Inc&rft.date=2014-08-19&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08809499%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true